Hypophosphatasia Treatment Market Expands as Strensiq Costs and...

добавлена новая статья Health

2026-08-12 05:26:40 -

Hypophosphatasia Treatment Market Expands as Strensiq Costs and Pipeline Innovation Shape Care

hypophosphatasia is an ultra-rare inherited metabolic disorder caused by pathogenic changes in the ALPL gene, leading to deficient tissue-nonspecific alkaline phosphatase activity. This disruption can affect bone and dental mineralization, with disease severity ranging from life-threatening perinatal presentations to less severe adult-onset manifestations. DelveInsight estimates around 6,200...

0 Комментарии 0 Поделились 206 Просмотры 0 предпросмотр